Emergent BioSolutions Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Gaithersburg, MD
SEC filing record 1 source field available
Fiscal year end
31 December
Emergent BioSolutions Inc. has filed 1,714 SEC EDGAR filings since 14 Aug 2006

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
4

FORM 4

Filing date
11 Feb 2025
Reporting date
09 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Dec 2024
Reporting date
15 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Dec 2024
Reporting date
08 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283150

EFFECT filing

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283150

424B3

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-283150

S-1/A

Filing date
02 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
21 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283150

UPLOAD filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Nov 2024
Reporting date
12 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Nov 2024
Reporting date
11 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Nov 2024
Reporting date
11 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-82602

EMERGENT BIOSOLUTIONS INC.

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-33137

144 filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
12 Nov 2024
Reporting date
29 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-283150

S-1

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-33137

144 filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82602

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Oct 2024
Reporting date
15 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .